Denne side blev automatisk oversat, og nøjagtigheden af ​​oversættelsen er ikke garanteret. Der henvises til engelsk version for en kildetekst.

Echocardiographic Screening of Healthy Neonates for Measuring Pulmonary Artery Pressure

2. november 2021 opdateret af: Marwa Mohamed Farag
The aim of the present prospective study was to evaluate dynamic changes in both pulmonary artery pressure and ductus arteriosus during the first 72 hours after birth.

Studieoversigt

Status

Afsluttet

Detaljeret beskrivelse

Healthy newborn infants born in Alexandria University Children's Hospital were studied. Dynamic changes during the first 72 hours after birth were evaluated.

Undersøgelsestype

Observationel

Tilmelding (Faktiske)

110

Kontakter og lokationer

Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.

Studiesteder

      • Alexandria, Egypten, 21131
        • Neonatal Intensive Care Unit (NICU) of Alexandria University Maternity Hospital.

Deltagelseskriterier

Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.

Berettigelseskriterier

Aldre berettiget til at studere

1 sekund til 6 timer (Barn)

Tager imod sunde frivillige

Ingen

Køn, der er berettiget til at studere

Alle

Prøveudtagningsmetode

Ikke-sandsynlighedsprøve

Studiebefolkning

Healthy newborn infants born in Alexandria University Children's Hospital were studied. Dynamic changes in both pulmonary artery pressure and ductus arteriosus during the first 72 hours after birth were evaluated.

Beskrivelse

Inclusion Criteria:

  • Gestational age: 37-42 weeks.
  • Birthweight: 2500-4000 g.

Exclusion Criteria:

  • Neonates more than 6 hours of age at time of enrollment.
  • Perinatal asphyxia or hypoxia (1 min Apgar scoring<7 points)
  • Cardiac structural abnormalities detected by echocardiography except patent foramen ovale and patent ductus arteriosus
  • Other clinically detected congenital malformations such as cleft lip and palate, omphalocele, meningocele, etc.
  • Maternal history of gestational hypertension, gestational diabetes, hyperthyroidism, hypothyroidism, and autoimmune disease

Studieplan

Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.

Hvordan er undersøgelsen tilrettelagt?

Design detaljer

Hvad måler undersøgelsen?

Primære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Pulmonary artery pressure (PAP) assessment - Tricuspid valve regurgitation peak velocity
Tidsramme: up to 72 hours

This is measured in apical 4 chamber view, with continuous wave Doppler using modified Bernoulli equation. Systolic pulmonary artery pressure is equivalent to right ventricular systolic pressure in absence of outflow obstruction.

Systolic Pulmonary Artery Pressure (SPAP) = Right Ventricular Systolic Pressure = 4x TR2 + Right Atrial Pressure (RAP) (RAP= 3-5 mmHg)

up to 72 hours
Pulmonary artery pressure (PAP) assessment - Pulmonary regurgitation peak velocity
Tidsramme: up to 72 hours
This is measured in short axis parasternal view with continuous wave Doppler using this equation: Mean Pulmonary Artery Pressure MPAP= 4xPR2 + Right Ventricular Diastolic Pressure (RVdP=2-5 mmHg)
up to 72 hours
Pulmonary artery pressure (PAP) assessment - Transductal right-to-left flow peak velocity
Tidsramme: up to 72 hours
This is measured in high short axis ductal view with continuous wave Doppler
up to 72 hours
Pulmonary artery pressure (PAP) assessment - Interventricular septum configuration
Tidsramme: up to 72 hours
This is measured in short axis parasternal view above level of papillary muscles, left ventricle is normally O shaped, D or crescent shape indicated bowing of septum due to RV dysfunction.
up to 72 hours
Pulmonary artery pressure (PAP) assessment - Left ventricle systolic eccentricity index (LV-sEI)
Tidsramme: up to 72 hours
This is measured in short axis parasternal view by measuring LV dimensions the parallel versus the perpendicular dimension. The normal ratio is 1.
up to 72 hours
Right ventricular performance - Tricuspid annular plane systolic excursion(TAPSE)
Tidsramme: up to 72 hours
This is measured using Mmode in apical 4 chamber view over lateral annulus of tricuspid valve
up to 72 hours
Right ventricular performance - Myocardial Performance Index (MPI)
Tidsramme: up to 72 hours
This is measured by using pulsed wave doppler to measure isovolumetric ejection time + isovolumetric relaxation time/ right ventricular ejection time.
up to 72 hours
Right ventricular performance - E/A ratio
Tidsramme: up to 72 hours
This is measured in apical 4 chamber view by pulsed wave Doppler on mitral valve. The cut off value: 0.8- 2.
up to 72 hours
Left ventricular performance - Ejection fraction
Tidsramme: up to 72 hours
This is measured using M-Mode in long axis parasternal view with a normal range of 55-75%
up to 72 hours
Left ventricular performance - E/A ratio
Tidsramme: up to 72 hours
This is measured in apical 4 chamber view by pulsed wave Doppler on mitral valve. The cut off value: 0.8- 2
up to 72 hours
Shunts evaluation - Patent Ductus arteriosus
Tidsramme: up to 72 hours
Size will be evaluated in short axis parasternal view
up to 72 hours
Shunts evaluation - Patent Ductus arteriosus
Tidsramme: up to 72 hours
Direction will be evaluated in short axis parasternal view using color Doppler
up to 72 hours
Shunts evaluation - Patent Foramen Ovale
Tidsramme: up to 72 hours
Size will be evaluated in be viewed in subcostal view
up to 72 hours
Shunts evaluation - Patent Foramen Ovale
Tidsramme: up to 72 hours
Direction will be evaluated in subcostal view using color Doppler
up to 72 hours

Samarbejdspartnere og efterforskere

Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.

Efterforskere

  • Studieleder: Aly M Abdel-Mohsen, PhD, Faculty of Medicine, Alexandria University, Egypt
  • Ledende efterforsker: Rana EO Kandil, MBBCh, Faculty of Medicine, Alexandria University, Egypt
  • Studieleder: Mohamed A Khalifa, MBBCh, Faculty of Medicine, Alexandria University, Egypt

Datoer for undersøgelser

Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.

Studer store datoer

Studiestart (Faktiske)

1. august 2020

Primær færdiggørelse (Faktiske)

10. august 2021

Studieafslutning (Faktiske)

15. august 2021

Datoer for studieregistrering

Først indsendt

10. september 2021

Først indsendt, der opfyldte QC-kriterier

10. september 2021

Først opslået (Faktiske)

20. september 2021

Opdateringer af undersøgelsesjournaler

Sidste opdatering sendt (Faktiske)

4. november 2021

Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier

2. november 2021

Sidst verificeret

1. november 2021

Mere information

Begreber relateret til denne undersøgelse

Andre undersøgelses-id-numre

  • 0106488

Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter

Studerer et amerikansk FDA-reguleret lægemiddelprodukt

Ingen

Studerer et amerikansk FDA-reguleret enhedsprodukt

Ingen

Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .

Kliniske forsøg med Pulmonal hypertension hos nyfødte

Abonner